Berry Street Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Berry Street Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,500	Closed	-$2.75M	–	87
2021 Q4	$2.75M	Buy	+12,500	New	+$2.43M	0.28%	50
2021 Q3	–	Sell	-12,500	Closed	-$2.52M	–	92
2021 Q2	$2.52M	Sell	12,500 -17,500	-58%	-$3.66M	0.22%	46
2021 Q1	$6.45M	Buy	+30,000	New	+$6.59M	0.71%	30

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Berry Street Capital Management's VRTX Position: Q1 2022 in Review

Berry Street Capital Management sold out of Vertex Pharmaceuticals (VRTX) in Q1 2022, closing a stake of 12,500 shares — an estimated $2.75M sold.

Berry Street Capital Management first reported a position in VRTX in Q1 2021 and held it in 3 quarters. The position peaked at $6.45M in Q1 2021. 1,071 funds tracked by Wall St. Rank hold VRTX as of Q1 2022.

Berry Street Capital Management reported no remaining Vertex Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Berry Street Capital Management sold 12,500 Vertex Pharmaceuticals shares in Q1 2022, an estimated $2.75M.
Berry Street Capital Management first reported a position in Vertex Pharmaceuticals in Q1 2021 and held it in 3 quarters.
Berry Street Capital Management's Vertex Pharmaceuticals position peaked at $6.45M in Q1 2021.
1,071 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2022.

Based on Berry Street Capital Management's 13F filing for Q1 2022, filed 13 May 2022.